NCCN Guidelines for Patients® help people with cancer talk with their doctors about the best treatment options for their disease. NCCN translates these patient resources into multiple languages so that they may be accessed by patients and
care providers around the world.
View All Patient Resources View Library of Patient Guidelines
Guidelines for Patients® Blood Clots and Cancer Version 2023 (Arabic)
Guidelines for Patients® Chronic Lymphocytic Leukemia Version 2021 (Arabic)
Guidelines for Patients® Colon Cancer Version 2022 (Arabic)
Guidelines for Patients® Colorectal Cancer Screening Version 2021 (Arabic)
Guidelines for Patients® Diffuse Large B-Cell Lymphomas Version 2022 (Arabic)
Guidelines for Patients® Myeloproliferative Neoplasms Version 2024 (Arabic)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Arabic)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Arabic)
Guidelines for Patients® Pancreatic Cancer Version 2023 (Arabic)
Guidelines for Patients® Prostate Cancer: Advanced Stage Version 2024 (Arabic)
Guidelines for Patients® Prostate Cancer: Early Stage Version 2024 (Arabic)
Guidelines for Patients® Small Cell Lung Cancer Version 2024 (Arabic)
Guidelines for Patients® Uterine Cancer Version 2023 (Arabic)
Guidelines for Patients® Blood Clots and Cancer Version 2023 (Chinese)
Guidelines for Patients® Brain Cancer - Glioma Version 2021 (Chinese)
Guidelines for Patients® Colorectal Cancer Screening Version 2021 (Chinese)
Guidelines for Patients® Diffuse Large B-Cell Lymphomas Version 2022 (Chinese)
Guidelines for Patients® Multiple Myeloma Version 2023 (Chinese)
Guidelines for Patients® Myeloproliferative Neoplasms Version 2024 (Chinese)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Chinese)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Chinese)
Guidelines for Patients® Pancreatic Cancer Version 2023 (Chinese)
Guidelines for Patients® Prostate Cancer: Advanced Stage Version 2024 (Chinese)
Guidelines for Patients® Prostate Cancer: Early Stage Version 2024 (Chinese)
Guidelines for Patients® Small Cell Lung Cancer Version 2024 (Chinese)
Guidelines for Patients® Uterine Cancer Version 2023 (Chinese)
Guidelines for Patients® Blood Clots and Cancer Version 2023 (French)
Guidelines for Patients® Colorectal Cancer Screening Version 2021 (French)
Guidelines for Patients® Diffuse Large B-Cell Lymphomas Version 2022 (French)
Guidelines for Patients® Multiple Myeloma Version 2023 (French)
Guidelines for Patients® Myeloproliferative Neoplasms Version 2024 (French)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (French)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (French)
Guidelines for Patients® Pancreatic Cancer Version 2023 (French)
Guidelines for Patients® Small Cell Lung Cancer Version 2024 (French)
Guidelines for Patients® Uterine Cancer Version 2023 (French)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (German)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (German)
Guidelines for Patients® Colorectal Cancer Screening Version 2021 (Haitian Creole)
Guidelines for Patients® Blood Clots and Cancer Version 2023 (Hindi)
Guidelines for Patients® Colorectal Cancer Screening Version 2021 (Hindi)
Guidelines for Patients® Myeloproliferative Neoplasms Version 2024 (Hindi)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Hindi)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Hindi)
Guidelines for Patients® Pancreatic Cancer Version 2023 (Hindi)
Guidelines for Patients® Prostate Cancer: Advanced Stage Version 2024 (Hindi)
Guidelines for Patients® Prostate Cancer: Early Stage Version 2024 (Hindi)
Guidelines for Patients® Small Cell Lung Cancer Version 2024 (Hindi)
Guidelines for Patients® Uterine Cancer Version 2023 (Hindi)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Hungarian)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Hungarian)
Guidelines for Patients® Colorectal Cancer Screening Version 2021 (Korean)
Guidelines for Patients® Multiple Myeloma Version 2022 (Korean)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2021 (Korean)
Guidelines for Patients® Colorectal Cancer Screening Version 2021 (Polish)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Polish)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Polish)
Guidelines for Patients® Small Cell Lung Cancer Version 2024 (Polish)
Guidelines for Patients® Blood Clots and Cancer Version 2023 (Portuguese)
Guidelines for Patients® Colorectal Cancer Screening Version 2021 (Portuguese)
Guidelines for Patients® Diffuse Large B-Cell Lymphomas Version 2022 (Portuguese)
Guidelines for Patients® Myeloproliferative Neoplasms Version 2024 (Portuguese)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Portuguese)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Portuguese)
Guidelines for Patients® Small Cell Lung Cancer Version 2024 (Portuguese)
Guidelines for Patients® Acute Lymphoblastic Leukemia (pediatric) Version 2021 (Russian)
Guidelines for Patients® Acute Myeloid Leukemia Version 2020 (Russian)
Guidelines for Patients® Bone Cancer Version 2021 (Russian)
Guidelines for Patients® Colorectal Cancer Screening Version 2021 (Russian)
Guidelines for Patients® Melanoma: Cutaneous - Melanoma Version 2021 (Russian)
Guidelines for Patients® Myelodysplastic Syndromes Version 2021 (Russian)
Guidelines for Patients® Myeloproliferative Neoplasms Version 2024 (Russian)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Russian)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Russian)
Guidelines for Patients® Ovarian Cancer Version 2021 (Russian)
Guidelines for Patients® Uterine Cancer Version 2021 (Russian)
Guidelines for Patients® Acute Myeloid Leukemia Version 2024 (Spanish)
Guidelines for Patients® Bladder Cancer Version 2024 (Spanish)
Guidelines for Patients® Blood Clots and Cancer Version 2023 (Spanish)
Guidelines for Patients® Breast Cancer - Ductal Carcinoma In Situ Version 2023 (Spanish)
Guidelines for Patients® Breast Cancer - Inflammatory Breast Cancer Version 2023 (Spanish)
Guidelines for Patients® Breast Cancer - Invasive Breast Cancer Version 2023 (Spanish)
Guidelines for Patients® Breast Cancer - Metastatic Breast Cancer Version 2023 (Spanish)
Guidelines for Patients® Breast Cancer Screening and Diagnosis Version 2022 (Spanish)
Guidelines for Patients® Chronic Myeloid Leukemia Version 2025 (Spanish)
Guidelines for Patients® Colorectal Cancer Screening Version 2024 (Spanish)
Guidelines for Patients® Cutaneous B-Cell Lymphomas Version 2024 (Spanish)
Guidelines for Patients® Cutaneous T-Cell Lymphomas Version 2024 (Spanish)
Guidelines for Patients® Diffuse Large B-Cell Lymphomas Version 2022 (Spanish)
Guidelines for Patients® Follicular Lymphoma Version 2024 (Spanish)
Guidelines for Patients® Immunotherapy Side Effects: Immune Checkpoint Inhibitors Version 2022 (Spanish)
Guidelines for Patients® Kidney Cancer Version 2025 (Spanish)
Guidelines for Patients® Lung Cancer Screening Version 2023 (Spanish)
Guidelines for Patients® Marginal Zone Lymphomas Version 2024 (Spanish)
Guidelines for Patients® Melanoma: Cutaneous - Melanoma Version 2024 (Spanish)
Guidelines for Patients® Multiple Myeloma Version 2025 (Spanish)
Guidelines for Patients® Myelodysplastic Syndromes Version 2024 (Spanish)
Guidelines for Patients® Myeloproliferative Neoplasms Version 2024 (Spanish)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Spanish)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Spanish)
Guidelines for Patients® Ovarian Cancer Version 2024 (Spanish)
Guidelines for Patients® Pancreatic Cancer Version 2023 (Spanish)
Guidelines for Patients® Prostate Cancer: Advanced Stage Version 2024 (Spanish)
Guidelines for Patients® Prostate Cancer: Early Stage Version 2024 (Spanish)
Guidelines for Patients® Quitting Smoking Version 2024 (Spanish)
Guidelines for Patients® Small Cell Lung Cancer Version 2024 (Spanish)
Guidelines for Patients® Thyroid Cancer Version 2024 (Spanish)
Guidelines for Patients® Uterine Cancer Version 2023 (Spanish)
Guidelines for Patients® Cervical Cancer Version 2022 (Ukrainian)
Guidelines for Patients® Colon Cancer Version 2021 (Ukrainian)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2021 (Ukrainian)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2021 (Ukrainian)
Guidelines for Patients® Ovarian Cancer Version 2021 (Ukrainian)
Guidelines for Patients® Colorectal Cancer Screening Version 2021 (Vietnamese)
Guidelines for Patients® Non-Small Cell Lung Cancer - Early and Locally Advanced Version 2024 (Vietnamese)
Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Vietnamese)
NCCN MAKES NO REPRESENTATIONS OR WARRANTIES CONCERNING THE NCCN CONTENT, THE NCCN GUIDELINES OR DERIVATIVE RESOURCES PROVIDED BY NCCN, ALL OF WHICH ARE PROVIDED "AS IS." NCCN DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. NCCN DOES NOT WARRANT THE ACCURACY, APPROPRIATENESS, APPLICABILITY OR COMPLETENESS OF THE NCCN CONTENT, THE NCCN GUIDELINES OR ANY DERIVATIVE RESOURCES, NOR DOES NCCN MAKE ANY REPRESENTATIONS REGARDING THE USE OR RESULTS OF THE USE OF THE NCCN CONTENT, THE NCCN GUIDELINES OR ANY SUCH DERIVATIVE RESOURCES.
NCCN EXPLICITLY DISCLAIMS THE APPROPRIATENESS OR APPLICABILITY OF THE NCCN CONTENT, THE NCCN GUIDELINES, AND ANY DERIVATIVE RESOURCES, OR THE USE OR APPLICATION OF THE NCCN CONTENT, THE NCCN GUIDELINES OR ANY SUCH DERIVATIVE RESOURCES, TO ANY SPECIFIC PATIENT'S CARE OR TREATMENT. ANY CLINICIAN SEEKING TO APPLY OR CONSULT THE NCCN CONTENT, THE NCCN GUIDELINES AND/OR ANY DERIVATIVE RESOURCES IS EXPECTED TO USE INDEPENDENT MEDICAL JUDGMENT IN THE CONTEXT OF THE INDIVIDUAL CLINICAL CIRCUMSTANCES TO DETERMINE ANY PATIENT'S CARE OR TREATMENT.